DAVENPORT & Co LLC cut its stake in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Free Report) by 29.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 485,412 shares of the company’s stock after selling 200,225 shares during the quarter. DAVENPORT & Co LLC owned about 20.40% of ALPS Medical Breakthroughs ETF worth $18,863,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of the stock. Jones Financial Companies Lllp purchased a new stake in shares of ALPS Medical Breakthroughs ETF during the 1st quarter valued at about $782,000. Strategic Financial Services Inc. raised its stake in shares of ALPS Medical Breakthroughs ETF by 97.8% during the second quarter. Strategic Financial Services Inc. now owns 38,032 shares of the company’s stock valued at $1,144,000 after purchasing an additional 18,807 shares during the period. Moran Wealth Management LLC acquired a new position in shares of ALPS Medical Breakthroughs ETF during the second quarter worth $300,000. Ally Invest Advisors Inc. purchased a new position in shares of ALPS Medical Breakthroughs ETF in the second quarter valued at $200,000. Finally, Raymond James Financial Inc. acquired a new stake in ALPS Medical Breakthroughs ETF during the 2nd quarter valued at $82,000.
ALPS Medical Breakthroughs ETF Stock Up 2.0%
ALPS Medical Breakthroughs ETF stock opened at $52.90 on Thursday. ALPS Medical Breakthroughs ETF has a 12-month low of $22.33 and a 12-month high of $52.90. The firm’s fifty day moving average price is $47.17 and its 200 day moving average price is $38.88.
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
Featured Stories
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
